Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function
- PMID: 23212520
- DOI: 10.1182/blood-2012-06-439786
Langerhans cell homeostasis in mice is dependent on mTORC1 but not mTORC2 function
Abstract
The PI3K/Akt/mTOR pathway has emerged as a critical regulator of dendritic cell (DC) development and function. The kinase mTOR is found in 2 distinct complexes, mTORC1 and mTORC2. In this study, we show that mTORC1 but not mTORC2 is required for epidermal Langerhans cell (LC) homeostasis. Although the initial seeding of the epidermis with LCs is not affected, the lack of mTORC1 activity in DCs by conditional deletion of Raptor leads to a progressive loss of LCs in the skin of mice. Ablation of mTORC2 function by deletion of Rictor results in a modest reduction of LCs in skin draining lymph nodes. In young mice Raptor-deficient LCs show an increased tendency to leave the skin, leading to a higher frequency of migratory DCs in skin draining lymph nodes, indicating that the loss of LCs results from enhanced migration. LCs lacking Raptor are smaller and display reduced expression of Langerin, E-cadherin, β-catenin, and CCR7 but unchanged levels of MHC-II, ruling out enhanced spontaneous maturation. Ki-67 and annexin V stainings revealed a faster turnover rate and increased apoptosis of Raptor-deficient LCs, which might additionally affect the preservation of the LC network. Taken together our results show that the homeostasis of LCs strictly depends on mTORC1.
Similar articles
-
mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.J Endocrinol. 2013 Jan 2;216(1):21-9. doi: 10.1530/JOE-12-0351. Print 2013 Jan. J Endocrinol. 2013. PMID: 23092880
-
TGF-beta is required to maintain the pool of immature Langerhans cells in the epidermis.J Immunol. 2010 Sep 15;185(6):3248-55. doi: 10.4049/jimmunol.1000981. Epub 2010 Aug 16. J Immunol. 2010. PMID: 20713882
-
Predominance of mTORC1 over mTORC2 in the regulation of proliferation of ovarian cancer cells: therapeutic implications.Mol Cancer Ther. 2012 Jun;11(6):1342-52. doi: 10.1158/1535-7163.MCT-11-0723. Epub 2012 Apr 10. Mol Cancer Ther. 2012. PMID: 22496482
-
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.Curr Cancer Drug Targets. 2016;16(4):288-304. doi: 10.2174/1568009616666151113120830. Curr Cancer Drug Targets. 2016. PMID: 26563881 Review.
-
RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes.Anticancer Drugs. 2016 Jul;27(6):475-87. doi: 10.1097/CAD.0000000000000354. Anticancer Drugs. 2016. PMID: 26918392 Free PMC article. Review.
Cited by
-
Early antitumor activity of oral Langerhans cells is compromised by a carcinogen.Proc Natl Acad Sci U S A. 2022 Jan 18;119(3):e2118424119. doi: 10.1073/pnas.2118424119. Proc Natl Acad Sci U S A. 2022. PMID: 35012988 Free PMC article.
-
The lysosomal Ragulator complex plays an essential role in leukocyte trafficking by activating myosin II.Nat Commun. 2021 Jun 7;12(1):3333. doi: 10.1038/s41467-021-23654-3. Nat Commun. 2021. PMID: 34099704 Free PMC article.
-
The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis.Blood. 2014 Jan 9;123(2):217-27. doi: 10.1182/blood-2013-08-518555. Epub 2013 Oct 3. Blood. 2014. PMID: 24092934 Free PMC article.
-
MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.Immunity. 2017 May 16;46(5):730-742. doi: 10.1016/j.immuni.2017.04.028. Immunity. 2017. PMID: 28514674 Free PMC article. Review.
-
mTOR-Mediated Regulation of Dendritic Cell Differentiation and Function.Trends Immunol. 2016 Nov;37(11):778-789. doi: 10.1016/j.it.2016.08.009. Epub 2016 Sep 7. Trends Immunol. 2016. PMID: 27614799 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous